Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1143
TNBC
Basal A
TAPI-0
TACE/Collagenase
7430.096
uM
inf
999.99990
0.7702 0.3543 0.1950 0.0991
0.6784
2.0162
HCC1143
TNBC
Basal A
Taxol
TUBB
TUBB
9233.002
uM
0.020
0.02774
-0.4917 -0.4178 1.8553 0.7713
0.9932
0.9358
HCC1143
TNBC
Basal A
Taxol
TUBB
TUBB
7810.002
uM
0.01074
0.01641
-0.4474 -0.4159 1.4293 0.8227
0.9941
1.1625
HCC1143
TNBC
Basal A
TCS 2312
CHK1
CHK
12112.159
uM
0.31472
0.40098
-0.3586 -0.3324 2.1041 0.4622
0.9941
1.8609
HCC1143
TNBC
Basal A
TCS PIM-1 1
Pim kinase
PIM
12112.135
uM
inf
inf
0.7748 0.7748 0.0000 0.0840
0.3883
1.8185
HCC1143
TNBC
Basal A
Temsirolimus
MTOR
MTOR
12112.144
uM
3.08980
23.90030
-0.8230 -1.0000 0.5370 0.4266
0.8180
1.9163
HCC1143
TNBC
Basal A
Topotecan
TOP1
TOP
9233.121
uM
0.16811
1.07840
-0.6689 -0.7583 0.4965 0.6340
0.9803
0.9468
HCC1143
TNBC
Basal A
Topotecan
TOP1
TOP
7810.007
uM
0.26583
1.0380
-0.7669 -0.7962 0.6993 0.6310
0.9903
0.9616
HCC1143
TNBC
Basal A
Torkinib
15349.211
uM
0.00212
0.02884
-0.5325 -0.6450 0.3174 0.9231
0.9841
1.2538
HCC1143
TNBC
Basal A
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12112.16
uM
1.5480
34.97250
-0.0267 -1.0000 0.3524 0.2951
0.9667
1.7073
HCC1143
TNBC
Basal A
TPCA-1
IKK
NFKB
7430.093
uM
10.07660
4.31640
0.4563 0.4520 2.7641 0.1304
0.9765
1.9432
HCC1143
TNBC
Basal A
Trametinib
MEK
MAPK
7810.012
uM
inf
0.00809
0.5737 0.5441 2.0492 0.2622
0.9610
0.9298
HCC1143
TNBC
Basal A
Trastuzumab
HER2
ErbB
9233.124
uM
inf
inf
0.8121 0.8121 0.0000 0.0617
0.3873
0.9990
HCC1143
TNBC
Basal A
Trichostatin A
HDAC
HDAC
7430.065
uM
16.73570
21.96270
-0.5867 -0.4256 2.2657 0.5930
0.9879
1.9263
HCC1143
TNBC
Basal A
Triciribine
AKT
AKT
7430.074
uM
3.52560
68.90220
0.1321 -0.9991 0.3694 0.2363
0.9801
1.6943
HCC1143
TNBC
Basal A
Valproic acid
HDAC
HDAC
12112.143
uM
987.2540
1000.00000
-0.2576 -0.0082 1.2700 0.1793
0.8673
1.6893
HCC1143
TNBC
Basal A
Vinorelbine
TUBB
TUBB
7810.006
uM
0.23157
0.26143
-0.7939 -0.1519 2.1883 0.6704
0.7555
0.9730
HCC1143
TNBC
Basal A
Vinorelbine
TUBB
TUBB
7809.018
uM
0.02987
0.02334
0.2866 0.3546 5.0000 0.3657
0.9630
1.6742
HCC1143
TNBC
Basal A
Vorinostat
HDAC
HDAC
7430.065
uM
143.29490
208.10230
-0.3499 -0.3272 1.3491 0.4600
0.9965
1.9263
HCC1143
TNBC
Basal A
XRP44X
ELK3
MAPK
12112.157
uM
11.75790
0.56131
0.5118 0.4877 1.2188 0.2507
0.7951
2.0505
HCC1143
TNBC
Basal A
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14203.189
uM
0.53646
0.96874
-0.8428 -0.8522 1.6834 0.6454
0.9944
1.6955
HCC1143
TNBC
Basal A
ZM-447439
AURK
AURK
12112.16
uM
2.1830
0.50095
0.4358 0.4738 2.0026 0.2316
0.9687
1.7073
HCC1187
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7812.016
uM
inf
inf
0.8355 0.8355 0.0000 0.0454
0.3718
1.0628
HCC1187
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7811.044
uM
11.65150
16.05880
-1.0000 -0.9995 3.4233 0.3459
0.9975
0.3073
HCC1187
TNBC
Basal A
17-AAG
HSP90
HSP90
7811.04
uM
1.04690
1.38930
-1.0000 -0.9258 3.7023 0.7792
0.8482
0.3921